Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study

References

• AutierPBoniolMLa VecchiaCVattenLGavinAHéryCHeanueMDisparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality databaseBMJ2010341c362020702548
   PubMed Web of Science ®Google Scholar
• BerryDACroninKAPlevritisSKCancer Intervention and Surveillance Modeling Network (CISNET) CollaboratorsEffect of screening and adjuvant therapy on mortality from breast cancerN Engl J Med2005353171784179216251534
   PubMed Web of Science ®Google Scholar
• CardosoFSpenceDMertzSGlobal analysis of advanced/metastatic breast cancer: decade report (2005–2015)Breast20183913113829679849
   PubMed Web of Science ®Google Scholar
• HowladerNNooneAMKrapchoM homepage on the InternetSEER Cancer Statistics Review, 1975–2013Bethesda, MDNational Cancer Institute Available from: http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to SEER web site, April 2016
   Google Scholar
• UfenMPKöhneCHWischneswkyMMetastatic breast cancer: are we treating the same patients as in the past?Ann Oncol20142519510024276026
   PubMed Web of Science ®Google Scholar
• PartridgeAHRumbleRBCareyLAChemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice GuidelineJ Clin Oncol201432293307332925185096
   PubMed Web of Science ®Google Scholar
• Al-MahmoodSSapiezynskiJGarbuzenkoOBMinkoTMetastatic and triple-negative breast cancer: challenges and treatment optionsDrug Deliv Transl Res2018851483150729978332
   PubMed Web of Science ®Google Scholar
• BianchiniGBalkoJMMayerIASandersMEGianniLTriple-negative breast cancer: challenges and opportunities of a heterogeneous diseaseNat Rev Clin Oncol2016131167469027184417
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)PetoRDaviesCComparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trialsLancet2012379981443244422152853
   PubMed Web of Science ®Google Scholar
• CortazarPZhangLUntchMPathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysisLancet2014384993816417224529560
   PubMed Web of Science ®Google Scholar
• CareyLADeesECSawyerLThe triple negative paradox: primary tumor chemosensitivity of breast cancer subtypesClin Cancer Res20071382329233417438091
   PubMed Web of Science ®Google Scholar
• DecatrisMPSundarSO’ByrneKJPlatinum-based chemotherapy in metastatic breast cancer: current statusCancer Treat Rev2004301538114766126
   PubMed Web of Science ®Google Scholar
• WangXWangXGuoZFunctionalization of platinum complexes for biomedical applicationsAcc Chem Res20154892622263126247558
   PubMed Web of Science ®Google Scholar
• DewiSLarsenSSrimuninnimitVBenzene-poly-carboxylic acid complex with cis-diammineplatinum (II) dichloride in the treatment of stage IV breast cancer patientsOpen Breast Cancer J20135715
   Google Scholar
• FaresFAzzamNFaresBLarsenSLindkaer-JensenSBenzene-poly-carboxylic acid complex, a novel anti-cancer agent induces apoptosis in human breast cancer cellsPLoS One201492e8515624523856
   PubMed Web of Science ®Google Scholar
• LarsenSButthongkomvongKManikhasABP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phaseBreast Cancer (Dove Med Press)2014617918925473312
   PubMedGoogle Scholar
• CarlsenKHKramerJFagertunHELarsenSLoratadine and terfena-dine in perennial allergic rhinitis. Treatment of nonresponders to the one drug with the other drugAllergy19934864314368238798
   PubMed Web of Science ®Google Scholar
• PocockSJClinical Trial; A Practical ApproachHoboken (NJ)John Wiley & Sons1989
   Google Scholar
• RazaliNWahYBPower comparisons of Shapiro-Wilk, Kolmogorov-Smirnov, Lilliefors and Anderson-Darling testsJ Stat Model Anal2011212133
   Google Scholar
• ThomopoulosNTStatistical Distributions; Applications and Parametric Estimation4th edCham, SwitzerlandSpringer International Publishing2017
   Google Scholar
• SchottJRMatrix Analysis for StatisticsHoboken (NJ)John Wiley & Sons2017
   Google Scholar
• AltmanDGPractical Statistic for Medical Research1st edLondonChapman & Hall1991
   Google Scholar
• AgrestiACategorical Data Analysis2nd edHoboken (NJ)John Wiley & Sons2002
   Google Scholar
• National Research CouncilThe Prevention and Treatment of Missing Data in Clinical TrialsWashington (DC)National Academy Press2010110112
   Google Scholar
• ShaoJZhaonhBLast observation carry-forward and last observation analysisStat Med2013221524292441
   Web of Science ®Google Scholar
• TabachnickBGFidellLSUsing Multivariate Statistics5th edBostonPearson Education Inc2007
   Google Scholar
• EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer200945222824719097774
   PubMed Web of Science ®Google Scholar
• RosenbergBVancampLTroskoJEMansourVHPlatinum compounds: a new class of potent antitumour agentsNature196922251913853865782119
   PubMed Web of Science ®Google Scholar
• RozencweigMNicaiseCBeerMPhase I study of carboplatin given on a five-day intravenous scheduleJ Clin Oncol19831106216266366128
   PubMed Web of Science ®Google Scholar
• GalluzziLMarsiliSVitaleIVitamin B6 metabolism influences the intracellular accumulation of cisplatinCell Cycle201312341742123287530
   PubMed Web of Science ®Google Scholar
• MarracheSPathakRKDharSDetouring of cisplatin to access mitochondrial genome for overcoming resistanceProc Natl Acad Sci U S A201411129104441044925002500
   PubMed Web of Science ®Google Scholar
• AnisimovVNLarsenSLofbergSBalduevaIAResults and prospects of development of new polyphenolic drugs for cancer patientsOncotarget2017859100951100956
   Google Scholar
• KristiansenVMDewiSHorsbergTETolerability and pharmacokinetic profile of a novel benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride in dogs with malignant mammary tumoursVet Comp Oncol201715111813225764447
   PubMed Web of Science ®Google Scholar
• CorbettTValerioteFLorussoPIn vivo methods for screening and preclinical testing: use of rodents solid tumors for drug discoveryTei-cherBAAnticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and ApprovalNew YorkSpringer201375101
   Google Scholar
• GuldbergPFangJFKirkinADzhandzhougazianKImmunological Study of BP-C1 and the Related Compounds. Cancer Genomic LaboratoryCopenhagenInstitute of Cancer Biology, Danish Cancer Society2011
   Google Scholar
• Lindkær-JensenSLarsenSHabib-Lindkær-JensenNFagertunHEPositive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substanceDrug Des Devel Ther2015914811490
   PubMedGoogle Scholar